rTMS for Chronic Fatigue Syndrome: Where Neural Circuits Are Restored and Rewired · London

rTMS has a growing evidence base for chronic pain and chronic fatigue syndrome. In conditions like fibromyalgia and central sensitisation, trials show meaningful pain reduction after 10–20 sessions, with effects sustained through neuroplasticity. For CFS and Long Covid fatigue, rTMS targets prefrontal circuits linked to energy and cognition, improving fatigue, brain fog, and mood. Early data at Naya show over 90% of patients experience improvement, compared to around 40% in standard care, though results vary and are not guaranteed.

Yes. Normal scan results do not mean your pain or fatigue is not real; they mean it is neurological rather than structural. Chronic pain and chronic fatigue that cannot be explained by structural damage are typically driven by central sensitisation, dysregulated neural circuits, and disrupted brain network communication. rTMS works at this neurological level, targeting the brain regions and circuits that generate and maintain the symptoms.

Chronic pain often isn't about damaged tissue; it's about a brain that's gotten stuck. There's a region responsible for moderating pain signals that becomes underactive over time, leaving pain to run unchecked. rTMS uses gentle magnetic pulses to stimulate that region back into doing its job, not masking the pain, but addressing the neurological pattern keeping it in place. And because the brain is genuinely changeable, those new patterns keep developing long after treatment ends. For many people, the relief continues to grow.

One of the things that makes rTMS quietly remarkable is how many different conditions it can reach and why that actually makes sense. Depression, anxiety, chronic pain, and chronic fatigue; all of them feel like very different experiences to live with. But beneath the surface, they often share something: a brain whose regulatory systems have gone offline, whose networks have stopped communicating the way they should. rTMS works at exactly that level. Which is why the same treatment, carefully personalised, can make a meaningful difference across all conditions. At Naya, early outcomes across all four presentations have been significantly above what standard care typically produces, something we believe comes down to the precision of our approach.

Yes. The neural circuits implicated in anxiety, low mood, and chronic pain overlap significantly, and they all involve dysregulation of prefrontal control over limbic and pain-processing networks. rTMS protocols can be targeted to address anxiety (through modulation of hyperactive fear circuits) and low mood (through activation of underactive motivational and reward networks) in the same treatment course.

rTMS produces lasting changes through neuroplasticity. This is not temporary symptom relief. For many patients, the improvements initiated by an rTMS course continue to develop and consolidate in the weeks and months following treatment as the brain reinforces its new patterns. Recurrence can occur in some patients, particularly under high stress or after significant life events, and maintenance treatment is available.

A TMS coil placed on the scalp delivers focused magnetic pulses that induce small electrical currents in targeted brain regions. These currents modulate neural activity, increasing underactive circuits or reducing overactive ones. With repeated sessions, this drives neuroplasticity, allowing more stable, regulated patterns to form. The treatment is non-invasive, requires no anaesthesia, and patients remain awake and comfortable. Because stimulation is localised, there are no systemic side effects.

Most fatigue treatment starts with the question: how do we help you manage this? Pacing, graded exercise, CBT, medication: these can all offer something, and for some people, they help. But they work around the fatigue, not with what's causing it at a neurological level. rTMS starts with a different question: what's actually happening in your brain? Chronic fatigue is often rooted in disrupted prefrontal networks, the circuits responsible for energy, arousal, and the feeling of being able to engage with life. When these go quiet, no amount of pacing or positive thinking can fully compensate. rTMS works by gently restoring activity in exactly those networks, helping your brain find its way back to patterns it's lost. At Naya, the NeuroScore™ assessment means we understand your specific neural profile before treatment begins, so what you receive isn't a standard fatigue protocol, but something built around what your brain actually needs. For people who've spent years being told to do less and rest more, that distinction can feel like someone finally asking the right question.

rTMS for chronic fatigue syndrome is not currently available on the NHS. NHS provision of rTMS is limited to treatment-resistant depression in specific clinical settings. Naya Health is a private clinic, and all treatment is self-funded or through private medical insurance. Private medical insurance recognition for Naya's services is in progress. For patients who have exhausted NHS pathways for chronic fatigue, including those with Long Covid, Naya offers a private route to evidence-based neurological treatment that is not currently accessible through public health channels.

Yes. rTMS is non-invasive, drug-free, and has no systemic side effects, making it suitable for patients who have tried other treatments. Contraindications include certain implanted metal devices and a history of seizures, which are assessed beforehand. For most chronic pain and fatigue patients, rTMS is safe and well-tolerated, with the most common sensation being mild tapping at the treatment site.